Zusammenfassung
Eine Vielzahl von Dermatosen wird durch eine epikutane Applikation von Wirksubstanzen therapiert. Planung, Konzeption, Durchführung und Überwachung der topischen Therapie zählen zu den Kernkompetenzen der Dermatologie. Dies setzt Grundlagenkenntnisse zur physikochemischen Organisation der Hautschichten, insbesondere des Stratum corneum, sowie zur Interaktion der Wirksubstanz und des Vehikelsystems mit dem Hautorgan voraus. Zudem sind pharmakokinetische Grundkenntnisse und die Besonderheiten für die epikutane Applikation notwendig, um professionell ärztlich handeln zu können.
Abstract
Numerous dermatoses are treated with topically applied substances. Planning, conception, implementation and monitoring of topical therapies are dermatological core competencies. This requires fundamental knowledge about the physicochemical structure of skin layers, especially the stratum corneum, as well as about the interaction of both the active substance and the vehicle system with the skin. Professional treatment also requires basic knowledge about pharmacokinetics and the special features of epicutaneous drug administration.
Literatur
Beltrani VS, Barsanti FA, Bielory L (2005) Effects of glucocorticosteroids on the skin and eye. Immunol Allergy Clin North Am 25:557–580
Hampton PJ, Reynolds NJ (2005) Calcineurin inhibitors for the treatment of skin disease: how do they work? Clin Exp Allergy 35:549–550
Schwabe U, Paffrath D (2013) Arzneiverordnungs-Report 2013. Springer, Berlin
Trommer H, Neubert RH (2006) Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol 19:106–121
Norlen L (2006) Stratum corneum keratin structure, function and formation – a comprehensive review. Int J Cosmet Sci 28:397–425
Rawlings AV, Voegeli R (2013) Stratum corneum proteases and dry skin conditions. Cell Tissue Res 351:217–235
Gloor M, Shabafrouz H (1983) Selection of the acceptor medium in in vitro measurements of drug release from dermatological ointments. Dermatologica 166:69–74
Williams ML, Elias PM (1987) The extracellular matrix of stratum corneum: role of lipids in normal and pathological function. Crit Rev Ther Drug Carrier Syst 3:95–122
Elias PM (1996) Stratum corneum architecture, metabolic activity and interactivity with subjacent cell layers. Exp Dermatol 5:191–201
Elias PM (2005) Stratum corneum defensive functions: an integrated view. J Invest Dermatol 125:183–200
Elias PM (2012) Structure and function of the stratum corneum extracellular matrix. J Invest Dermatol 132:2131–2133
Farwanah H, Wohlrab J, Neubert RH et al (2005) Profiling of human stratum corneum ceramides by means of normal phase LC/APCI-MS. Anal Bioanal Chem 383:632–637
Kessner D, Ruettinger A, Kiselev MA et al (2008) Properties of ceramides and their impact on the stratum corneum structure. Part 2: stratum corneum lipid model systems. Skin Pharmacol Physiol 21:58–74
Norlen L, Plasencia I, Bagatolli L (2008) Stratum corneum lipid organization as observed by atomic force, confocal and two-photon excitation fluorescence microscopy. Int J Cosmet Sci 30:391–411
Robinson M, Visscher M, Laruffa A et al (2010) Natural moisturizing factors (NMF) in the stratum corneum (SC). II. Regeneration of NMF over time after soaking. J Cosmet Sci 61:23–29
Robinson M, Visscher M, Laruffa A et al (2010) Natural moisturizing factors (NMF) in the stratum corneum (SC). I. Effects of lipid extraction and soaking. J Cosmet Sci 61:13–22
Kezic S, Kammeyer A, Calkoen F et al (2009) Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods. Br J Dermatol 161:1098–1104
Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56:603–618
Igawa S, Kishibe M, Murakami M et al (2011) Tight junctions in the stratum corneum explain spatial differences in corneodesmosome degradation. Exp Dermatol 20:53–57
Derendorf H, Lesko LJ, Chaikin P et al (2000) Pharmacokinetic/pharmacodynamic modeling in drug research and development. J Clin Pharmacol 40:1399–1418
Elias PM, Wakefield JS (2011) Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol 41:282–295
Rezeptur-Formulariums PLdN (2012) Standardisierte Rezepturen. Govi, Eschborn
Hafeez F, Maibach H (2013) Occlusion effect on in vivo percutaneous penetration of chemicals in man and monkey: partition coefficient effects. Skin Pharmacol Physiol 26:85–91
Einhaltung ethischer Richtlinien
Interessenkonflikt. J. Wohlrab gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wohlrab, J. Grundlagen der topischen Therapie. Hautarzt 65, 169–174 (2014). https://doi.org/10.1007/s00105-013-2654-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-013-2654-6